...
首页> 外文期刊>Toxicology Letters: An International Journal Providing a Forum for Original and Pertinent Contributions in Toxicology Research >Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritants.
【24h】

Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritants.

机译:CD34 +祖细胞衍生的树突状细胞区分敏化剂和刺激物的能力。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In an attempt to develop an in vitro test to identify contact sensitizers, mostly dendritic cells (DCs) derived from monocytes (Mo-DC) have been used. Less is known about the potency of DC derived from CD34+ progenitors (CD34-DC) for in vitro allergen testing. CD34+ progenitor derived DC were exposed to nine well-known allergens (one weak, three moderate and five strong allergens) and two irritants. Surface marker expression (CD86, CD83 and HLA-DR) and cytokine production (IL-6, IL-12 and TNF-alpha) were analyzed after 24 h exposure to these chemicals. All allergens tested induced a significant increase in at least one of the DC surface markers. In contrast, none of the irritants tested were able to significantly upregulate membrane marker expression in exposed DC. The level of upregulation of CD86, CD83 and HLA-DR was dependent on the nature and concentration of the chemical, but not on the classification of the allergen. Changes in cytokine production (IL-6, IL-12 and TNF-alpha) were not consistentlyrelated to exposure to an allergen. Based on these results, we conclude that the in vitro test using CD34-DC has the capacity to distinguish between allergens and irritants based on altered phenotypic characteristics.
机译:为了尝试开发鉴定接触敏化剂的体外试验,大多数使用了源自单核细胞(Mo-DC)的树突状细胞(DC)。关于CD34 +祖细胞(CD34-DC)的DC用于体外变应原测试的效力知之甚少。 CD34 +祖细胞衍生的DC暴露于9种众所周知的过敏原(一种弱,三种中等和五种强过敏原)和两种刺激物。接触这些化学物质24小时后,分析了表面标志物的表达(CD86,CD83和HLA-DR)和细胞因子的产生(IL-6,IL-12和TNF-α)。测试的所有过敏原均导致至少一种DC表面标记物显着增加。相反,所测试的刺激物均不能显着上调暴露的DC中的膜标志物表达。 CD86,CD83和HLA-DR的上调水平取决于化学物质的性质和浓度,而不取决于过敏原的分类。细胞因子产生的变化(IL-6,IL-12和TNF-α)与暴露于变应原并非始终相关。根据这些结果,我们得出结论,使用CD34-DC进行的体外测试具有根据改变的表型特征区分过敏原和刺激物的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号